Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 SEK | +0.37% | +3.44% | -66.08% |
15/05 | Transcript : Scandion Oncology A/S - Special Call | |
21/03 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 01/17/01 |
Chief Executive Officer | 64 | 02/23/02 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 01/21/01 |
Lars Damstrup
CTO | Chief Tech/Sci/R&D Officer | - | 01/23/01 |
Corporate Officer/Principal | - | - | |
Morten Nissen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/22/01 | |
Director/Board Member | 69 | 07/18/07 | |
Martin Møller
CHM | Chairman | 49 | 01/21/01 |
Martine van Vugt
BRD | Director/Board Member | 71 | 01/22/01 |
Director/Board Member | 53 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,706,972 | 38,542,097 ( 94.68 %) | 0 | 94.68 % |
Company contact information
Scandion Oncology A/S
Symbion Fruebjergvej 3
2100, Copenhagen
+45 38 10 20 17
http://www.scandiononcology.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.08% | 51.44L | |
+8.29% | 11TCr | |
+10.21% | 11TCr | |
+0.41% | 2.23TCr | |
-11.90% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.17% | 1.72TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- SCOL Stock
- Company Scandion Oncology A/S